Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status

From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma

(2013) Gavin P. Dunn et al.   Neurosurgical Focus

Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric

(2013) Maxwell Lewis Neal et al.   PLoS One

Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

(2012) J.A. Carrillo et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth

(2012) Catherine Gozé et al.   JOURNAL OF NEURO-ONCOLOGY

IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

(2011) Linda B. C. Bralten et al.   ANNALS OF NEUROLOGY

Quantifying the Role of Angiogenesis in Malignant Progression of Gliomas: In Silico Modeling Integrates Imaging and Histology

(2011) K. R. Swanson et al.   CANCER RESEARCH

Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?

(2011) J. G. Scott et al.   NEURO-ONCOLOGY

Tumour–stromal interactions in acid-mediated invasion: A mathematical model

(2010) Natasha K. Martin et al.   JOURNAL OF THEORETICAL BIOLOGY

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

(2010) Nanne K Kloosterhof et al.   LANCET ONCOLOGY

Predicting the efficacy of radiotherapy in individual glioblastoma patientsin vivo:a mathematical modeling approach

(2010) R Rockne et al.   PHYSICS IN MEDICINE AND BIOLOGY

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

(2009) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion

(2009) A. S. Silva et al.   CANCER RESEARCH

Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas

(2009) M. D. Szeto et al.   CANCER RESEARCH

Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical Model

(2009) C. H. Wang et al.   CANCER RESEARCH

IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas

(2009) S. Nobusawa et al.   CLINICAL CANCER RESEARCH

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

(2009) Koichi Ichimura et al.   NEURO-ONCOLOGY

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of the IDH1 codon 132 mutation in brain tumors

(2008) Jörg Balss et al.   ACTA NEUROPATHOLOGICA

Mathematical modelling of tumour acidity

(2008) Kieran Smallbone et al.   JOURNAL OF THEORETICAL BIOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE

Quantifying glioma cell growth and invasion in vitro

(2007) Kristin R. Swanson   MATHEMATICAL AND COMPUTER MODELLING